Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.
Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.
复制标题
DOI:
10.3389/fimmu.2014.00165
复制
发表时间:
2014
影响因子:
7.3
通讯作者:
De Vries IJ
中科院分区:
文献类型:
--
作者:
Wimmers F;Schreibelt G;Sköld AE;Figdor CG;De Vries IJ
Dendritic cell (DC)-based immunotherapy employs the patients’ immune system to fight neoplastic lesions spread over the entire body. This makes it an important therapy option for patients suffering from metastatic melanoma, which is often resistant to chemotherapy. However, conventional cellular vaccination approaches, based on monocyte-derived DCs (moDCs), only achieved modest response rates despite continued optimization of various vaccination parameters. In addition, the generation of moDCs requires extensive ex vivo culturing conceivably hampering the immunogenicity of the vaccine. Recent studies, thus, focused on vaccines that make use of primary DCs. Though rare in the blood, these naturally circulating DCs can be readily isolated and activated thereby circumventing lengthy ex vivo culture periods. The first clinical trials not only showed increased survival rates but also the induction of diversified anti-cancer immune responses. Upcoming treatment paradigms aim to include several primary DC subsets in a single vaccine as pre-clinical studies identified synergistic effects between various antigen-presenting cells.
登录
查看更多内容
影响因子:
30.5
作者:
Cella, M;Facchetti, F;Colonna, M
通讯作者:
Colonna, M
影响因子:
30.5
作者:
D'Amico, G;Frascaroli, G;Mantovani, A
通讯作者:
Mantovani, A
影响因子:
4.4
作者:
Bioley, Gilles;Jandus, Camilla;Romero, Pedro
通讯作者:
Romero, Pedro
影响因子:
45.3
作者:
Balch, Charles M.;Gershenwald, Jeffrey E.;Sondak, Vernon K.
通讯作者:
Sondak, Vernon K.
影响因子:
11.5
作者:
Aarntzen, Erik H. J. G.;Srinivas, Mangala;de Vries, I. Jolanda M.
通讯作者:
de Vries, I. Jolanda M.